Skip to content

Insider · CIK 0001776929

Jan De Witte

ceopresidentofficerdirector

Files at IART (INTEGRA LIFESCIENCES HOLDINGS CORP), RMD (RESMED INC). First filing Nov 14, 2024, latest Nov 14, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $198k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RMD: RESMED INC

RMDOct 9, 2026 · close 230.05

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
27Weak
RMDsell 610b5-1
RESMED INC
$198k
796 shares
-11%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 20, 2024RMD
RESMED INC
AGrant or award
ReMed Common Stock
+1,083$0.00$07,806Nov 22, 2024
Nov 12, 2024RMD
RESMED INC
SOpen-market sale
ReMed Common Stock10b5-1
-796$248.81$198k6,723Nov 14, 2024
Nov 1, 2024IART
INTEGRA LIFESCIENCES HOLDINGS CORP
MOption exercise
Common Stock
+9,814$0.00$028,164Nov 4, 2024
Nov 1, 2024IART
INTEGRA LIFESCIENCES HOLDINGS CORP
FTax withholding
Common Stock
-4,262$19.28$82k23,902Nov 4, 2024
Nov 1, 2024IART
INTEGRA LIFESCIENCES HOLDINGS CORP
MOption exercise
Restricted Stock Unitsderivative
-9,814$0.00$0120,466Nov 4, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jan De Witte: insider trades and track record | InsiderTell